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Abstract
Background: Human genetic variants may affect tuberculosis susceptibility, but the immunologic correlates of the
genetic variants identified are often unclear.
Methods: We conducted a pilot case-control study to identify genetic variants associated with extrapulmonary
tuberculosis in patients with previously characterized immune defects: low CD4+ lymphocytes and low
unstimulated cytokine production. Two genetic association approaches were used: 1) variants previously associated
with tuberculosis risk; 2) single nucleotide polymorphisms (SNPs) in candidate genes involved in tuberculosis
pathogenesis. Single locus association tests and multifactor dimensionality reduction (MDR) assessed main effects
and multi-locus interactions.
Results: There were 24 extrapulmonary tuberculosis cases (18 black), 24 pulmonary tuberculosis controls (19 black)
and 57 PPD+ controls (49 black). In approach 1, 22 SNPs and 3 microsatellites were assessed. In single locus
association tests, interleukin (IL)-1b +3953 C/T was associated with extrapulmonary tuberculosis compared to PPD+
controls (P = 0.049). Among the sub-set of patients who were black, genotype frequencies of the vitamin D
receptor (VDR) Fok1 A/G SNP were significantly different in extrapulmonary vs. pulmonary TB patients (P = 0.018).
In MDR analysis, the toll-like receptor (TLR) 2 microsatellite had 76% prediction accuracy for extrapulmonary
tuberculosis in blacks (P = 0.002). In approach 2, 613 SNPs in 26 genes were assessed. None were associated with
extrapulmonary tuberculosis.
Conclusions: In this pilot study among extrapulmonary tuberculosis patients with well-characterized immune
defects, genetic variants in IL-1b, VDR Fok1, and TLR2 were associated with an increased risk of extrapulmonary
disease. Additional studies of the underlying mechanism of these genetic variants are warranted.
Background
A possible genetic predisposition to tuberculosis has
been suggested in several studies,[1-3] but the functional
immunologic correlate of the genetic polymorphisms
identified is often unclear[4]. We have sought to first
identify immunologic defects that may predispose to
tuberculosis, then assess for genetic polymorphisms
associated with these immunologic defects. Because
there is evidence that extrapulmonary tuberculosis is the
result of an underlying immune defect, [5] we have
focused our search on persons with prior extrapulmon-
ary disease. In previous studies we noted that HIV-sero-
negative adults with prior extrapulmonary tuberculosis
had lower levels of CD4+ lymphocytes, unstimulated
cytokine production, and tumor necrosis factor (TNF)-a
production in response to lipopolysaccharide (LPS) or
LPS + interferon (IFN)-g than persons with prior pul-
monary tuberculosis or latent M. tuberculosis infection
[6,7].
I nt h ec u r r e n ts t u d yw eh a v ec o m b i n e dt w op r e v i o u s
study populations in which cytokine responses were
well-characterized, [6,7] to identify genetic
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losis, and by extension, the associated immunologic
abnormalities. We make use of a candidate gene
approach utilizing single nucleotide polymorphisms
(SNPs) and microsatellites previously reported to be
associated with tuberculosis, and we also include SNPs
in candidate genes that are hypothesized to play a role
in tuberculosis pathogenesis.
Because several loci could contribute to the phenotype
expressed in complex diseases such as tuberculosis, it is
important to search for gene-gene interactions (epista-
s i s ) ,w h i c hm a yg i v eam o r ea c c u r a t ep r e d i c t i o no fd i s -
ease risk. Such interactions are difficult to detect using
traditional statistical methods such as single locus asso-
ciation tests because those tests were not developed to
detect purely interactive effects. Such tests identify
genes with main effects and then follow-up analyses
assess for interactions between genes that exhibit a
main effect. New statistical and computational methods
that have better power to detect interactions, including
those without main effects, in relatively small sample
sizes, are required. Multifactor dimensionality reduction
( M D R )a n a l y s i si san o v e lm e t hod developed to address
this need[8]. In the current study both single locus asso-
ciation tests and MDR analysis were used to detect
potential single or multi-locus interactions that predict
extrapulmonary tuberculosis.
Results
Clinical and Demographic Characteristics
There were 24 extrapulmonary tuberculosis cases (18
black), 24 pulmonary tuberculosis controls (19 black),
and 57 controls (49 black) with latent M. tuberculosis
infection. The clinical and demographic characteristics
of the study population are in Table 1. There were no
significant differences between cases and controls
according to age, sex, or race. However, pulmonary con-
trols had lower median body mass index (BMI) at the
time of study than either extrapulmonary tuberculosis
c a s e so rc o n t r o l sw i t hl a t e n tM. tuberculosis infection.
Extrapulmonary tuberculosis cases had lower median
CD4+ lymphocytes at time of study than controls. The
sites of disease among extrapulmonary cases included
lymphatic (n = 9), pleural (n = 4), bone/joint (n = 4),
pericardial (n = 2), genito-urinary (n = 2), miliary/
meningeal (n = 1), gastrointestinal (n = 1), and laryngeal
(n = 1).
SNPs Associated with Tuberculosis in Previous Studies
Of the 27 SNPs and 3 microsatellites previously
reported in the literature as being associated with tuber-
culosis (Table 2), 25 SNPs and all 3 microsatellites were
assessed by PCR-based SNP genotyping. The IL-1b -511
(C®T) and vitamin D receptor (VDR) Bsm1S N P sw e r e
on the GeneChip® Human Mapping 50K Xba Array. Of
the 30 polymorphisms tested, 5 SNPs (rs 17235416,
rs1800450, rs5743708, rs6265786, rs2393799) were
unable to be genotyped after quality control and were
therefore excluded. Only markers with < 10% missing
data were considered for analysis. No imputation of
missing values was performed. For univariate analyses,
missing values were removed for analysis; for the MDR
analysis, missing observations were ignored, such that
attribute construction and accuracy calculations were
only performed based on observed values.
In single locus association testing of each polymorph-
ism among all study participants, the IL-1b +3953
(C®T) SNP was associated with any tuberculosis (P =
0.044) and extrapulmonary tuberculosis (P = 0.049)
compared to PPD+ controls (Table 3). Among black
patients, the Fok1 SNP in the VDR gene was associated
with extrapulmonary tuberculosis compared to pulmon-
ary tuberculosis controls (P = 0.018).
In MDR analysis of the 25 polymorphisms among all
study participants, the microsatellite in TLR2 (GT) had
61% prediction accuracy for any tuberculosis compared
to controls with M. tuberculosis infection (P = 0.038)
(Table 3). It also had 63% prediction accuracy for any
Table 1 Clinical and Demographic Characteristics of the Study Population
Characteristic Extrapulmonary TB (n = 24) Pulmonary TB (n = 24) PPD+ (n = 57) P value
a
Age at study entry (years) 48.4
(43.6-79.4)
43.6
(40.3-53.9)
45.7
(38.8-53.3)
0.18
# Male Sex (%) 16 (67) 14 (58) 36 (63) 0.84
# Black Race (%) 18 (75) 19 (79) 49 (86) 0.46
# White Race (%) 4 (17) 4 (17) 8 (14) 0.93
# Asian Race (%) 2 (9) 1 (4) 0 (0) 0.11
BMI at study entry (kg/m
2) 25.5
(23.0-29.6)
20.6
(18.2-24.0)
25.9
(22.8-30.5)
< 0.001
CD4 count at study entry 701
(565-1015)
814
(594-938)
879
(703-1114)
0.05
Data are medians (inter-quartile range; IQR) except as noted.
a Kruskal-Wallis test for continuous variables; Chi-square test for categorical variables.
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Page 2 of 10tuberculosis in blacks (P = 0.047) and 76% prediction
accuracy for extrapulmonary tuberculosis in blacks (P =
0.002). Results did not change when the analysis
included CD4+ lymphocytes and BMI as potential cov-
ariates (results not shown).
SNPs in Candidate Genes
There were 661 SNPs in genes presumed to be associated
with tuberculosis pathogenesis (Table 4), of which 613
(93%) had genotyping efficiency > 90% (i.e., < 10% miss-
ing data) and were included in the analysis. In the MDR
analysis of these 613 SNPs, an intronic SNP in TNF-a
(C®T) (rs1811063) predicted tuberculosis with 62%
accuracy among all patients (P = 0.05; Table 5). The
combination of two SNPs in TLR4 (C®T) (rs1399431)
and TNF-a (C®T) (rs7791836) predicted tuberculosis
risk with 71% accuracy in blacks (P = 0.02). Results did
not change when the analysis included CD4+ lympho-
cytes and BMI as potential covariates (results not
shown). There were no SNPs associated with extrapul-
monary tuberculosis compared to controls.
Discussion
In this study population we first identified immunologic
defects among persons with extrapulmonary tuberculosis,
then explored possible associations with candidate
Table 2 Polymorphisms Tested that had Previously Been
Reported as Associated with Tuberculosis
Gene SNP rs number References
NRAMP1
(Slc11a1)
5’(GT)n microsatellite —————— [1,22-26]
INT4 (469+14G/C) rs3731865 [1,26]
D543N rs17235409 [1,27,24,28,26]
3’UTR (1729+55del4) rs17235416 [1,27,28,26]
274C/T rs2276631 [29]
SP110 sp110 intron 6 rs2114592 [30]
sp110 exon 11 rs3948464 [30]
IL-12/23/IFN-g
Pathway
+874A/T rs2430561 [31-35]
-1616G rs2069705 [36]
+3234T rs2069718 [36]
IFNGR1 -56C/T rs2234711 [36]
IL-1 and IL-1
RA
IL-1a -899 C/T rs1800587 [37]
IL-1b +3953 C/T rs1143634 [38]
IL-1b -511 C/T rs16944 [39]
IL-1RA microsatellite —————— [40]
IL-10 -1082 G/A rs1800896 [41,34,42]
-592 A/C rs1800872 [43]
MBL Codon 52 C/T (allele
D)
rs5030737 [44]
Codon 54 A/G (allele
B)
rs1800450 [44]
Codon 57 A/G (allele
C)
rs1800451 [44]
VDR Taq1 C/T rs731236 [11,2,45]
Fok1 A/G rs10735810 [11,28]
Bsm1 rs154410 [45]
MCP-1 -2518A/G rs1024611 [46]
TIRAP C558T rs7932766 [47]
TLR2 GT repeat intII
microsatellite
——————— [18]
Arg753Gln rs5743708 [48]
Arg677Trp rs6265786 [49]
P2X7 -762T/C rs2393799 [50]
1513A/C rs3751143 [51]
Polymorphisms were reported in the literature prior to November 15, 2006.
There were 27 single nucleotide polymorphisms (SNPs) and three
microsatellites. The status of each polymorphism tested in this study is
provided.
Abbreviations (names of genes):
NRAMP-1 natural resistance-associated macrophage protein-1
SP110 speckled 110, nuclear hormone receptor co-activator
IL-12/23 interleukin-12/23
IFN-g interferon-gamma
IFNGR1 interferon-gamma receptor 1
VDR vitamin D receptor
IL-1 interleukin-1
MCP-1 monocyte chemoattractant protein-1
IL-1 RA interleukin-1 receptor antagonist
TIRAP toll-interleukin 1 receptor adapter protein
IL-10 interleukin-10
TLR2 toll-like receptor 2
MBL mannose binding lectin
P2X7 purinoreceptor
Table 3 Of the Polymorphisms Tested that had
Previously Been Reported as Associated with
Tuberculosis (Table 2), the SNPs Associated with
Tuberculosis in this Study
Comparator groups SNPs P-value
Single Locus Association Tests
All patients
Any TB vs. PPD+ IL-1beta +3953 0.044
ExtTB vs. PPD+ IL-1beta +3953 0.049
ExtTB vs. PulmTB none —
Black patients
Any TB vs. PPD+ none —
ExtTB vs. PPD+ none —
ExtTB vs. PulmTB VDR Fok1 0.018
Multifactor Dimensionality Reduction Analysis
All patients
Any TB vs. PPD+ TLR2 microsatellite 0.038#
ExtTB vs. PPD+ none —
ExtTB vs. PulmTB none —
Black patients
Any TB vs. PPD+ TLR2 microsatellite 0.047*
ExtTB vs. PPD+ TLR2 microsatellite 0.002^
ExtTB vs. PulmTB none —
SNPs with P ≤ 0.05 are listed. P-values are uncorrected.
# 61% prediction accuracy
* 63% prediction accuracy
^ 76% prediction accuracy
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genetic variants previously associated with tuberculosis
susceptibility, IL-1b +3953 was associated with extrapul-
monary disease, as well as all forms of tuberculosis, com-
pared to persons with M. tuberculosis infection. Among
black patients, the Fok1S N Pi nt h eV D Rg e n ed i s t i n -
guished extrapulmonary from pulmonary disease. The
MDR analysis provides important additional results, how-
ever, because it is more powerful than traditional logistic
regression analysis,[9] adjusts for multiple comparisons
via permutation testing, and because the results were
more consistent across the groups assessed. MDR also
evaluates potential gene-gene and gene-environment
interactions, which are important to investigate in com-
plex phenotypes such as tuberculosis pathogenesis. The
TLR2 microsatellite predicted extrapulmonary tuberculo-
sis in black patients with 76% accuracy. It also predicted
all forms of tuberculosis in blacks, as well as in the full
study population. The prediction accuracy estimates the
importance of variables in the dataset, with the intent of
generalizing the model to the full population.
These results point to the importance of IL-1b +3953,
VDR Fok1 A/G, and the TLR2 microsatellite in extra-
pulmonary tuberculosis risk, with the latter two being
particularly significant in blacks, even in such a small
sample size. This is important in light of the increased
proportion of extrapulmonary tuberculosis in blacks[5].
Further studies are needed to determine if these poly-
morphisms could account for this epidemiological find-
ing. This study included very few individuals of other
racial backgrounds, making comparisons of genetic
models between racial groups impossible. Our results
are consistent with the previously noted association
between IL-1b +3953 and tuberculous pleurisy, and
VDR Fok1 and several forms of extrapulmonary tuber-
culosis–both noted among in Gujarati Asians living in
London[10,11]. They are also consistent with the
recently identified link between TLR and the innate
immune response to M. tuberculosis: the relationship
between TLR signaling, the up-regulation of the VDR,
and vitamin D-mediated killing of intracellular M. tuber-
culosis via the microbial peptide cathelicidin[12]. In that
study, blacks had low 25-hydroxyvitamin D levels and
low cathelicidin messenger RNA induction. While
immediate biological interpretation of our results is not
possible, defects in M. tuberculosis recognition and/or
subsequent intracellular signaling in the nuclear factor
kappa B (NF-B) pathway related to TLR2 polymorph-
isms would be consistent with the subtle innate immune
defects in the extrapulmonary tuberculosis patients in
this study population: low unstimulated cytokine pro-
duction, decreased TNF-a production in response to
LPS or LPS + IFN-g, and low CD4+ lymphocytes[6,7,4].
The results from SNPs in genes hypothesized to play a
role in tuberculosis pathogenesis showed that no SNPs
were significantly associated with extrapulmonary tuber-
culosis. There was, however, a SNP in TNF-a that was
associated with tuberculosis among all study partici-
pants. And among blacks, a combination of SNPs in
TNF-a and TLR4 predicted tuberculosis risk with 71%
accuracy. These SNPs cannot be interpreted as easily in
light of the immunologic findings, which pertain to
extrapulmonary tuberculosis. However, they suggest that
similar cytokine pathways as those noted above are
important in tuberculosis pathogenesis.
It was notable that persons with prior extrapulmonary
tuberculosis or latent M. tuberculosis infection had sig-
nificantly higher body mass index (BMI) than persons
with pulmonary tuberculosis. If BMI after completion of
treatment is comparable to BMI prior to development
of disease, it would suggest that lower BMI may predis-
pose to pulmonary tuberculosis. It should be noted that
the median BMI in persons with pulmonary disease was
within the normal range, whereas BMI in persons in the
other two groups was high. A recent large population-
Table 4 Polymorphisms in the Affymetrix GeneChip®
Human Mapping 50K Xba Array in Genes Hypothesized
to be Associated with Tuberculosis Pathogenesis
Gene # SNPs Gene # SNPs Gene # SNPs
IL-4 4 GATA3 68 IFN-a 5
IL-6 11 TRAF6 3 CYLD 13
IL-8 5 HLA-DQ 5 BCL10 1
IL-10 4 HLA-DR 5 A20 28
IL-12 28 VDR 2 TAK1 7
TNF 191 NOD2/CARD15 1 STAT4 9
IFN-g 18 NF b 50 IL-23 6
IL-1b 2 STAT1 3 TLR4 21
RunX 66 TGF-b 105
The number of SNPs tested in each gene is provided. There were a total of
661 SNPs.
Table 5 Of the SNPs Listed in Table 4, the SNPs
Associated with Tuberculosis in This Study Population
RS
number
Gene Minor
Allele
Frequency
Average
Testing
Balanced
Accuracy
Cross-
validation
Consistency
P-value
Any TB vs. PPD+, all patients
Rs1811063 TNF-a 0.121 62.11
# 4/5 0.05
Any TB vs. PPD+, black patients
Rs1399431
Rs7791836
TLR4
TNF-a
0.401
0.5
71.27
^ 3/5 0.02
#Testing Sensitivity: 0.55; Testing Specificity: 0.69
^ Testing Sensitivity: 0.71; Testing Specificity: 0.72. In post-hoc logistic
regression analysis using these 2 SNPs, a recessive encoding for each SNP
maximized the model fit.
The above are Multifactor Dimensionality Reduction models. Only models with
P ≤ 0.05 are presented here.
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the risk of pulmonary tuberculosis decreased, but the
risk of extrapulmonary tuberculosis did not[13]. The
protective effect of increased BMI on pulmonary disease
in that study persisted even after controlling for con-
founding variables, including smoking and diabetes mel-
litus. The above findings suggest that risk factors for
extrapulmonary tuberculosis are not ameliorated by
increased BMI–which would be consistent with an
immunogenetic predisposition to extrapulmonary tuber-
culosis. Factors related to the M. tuberculosis strain also
play a role in extrapulmonary disease[14].
The most important limitation of the current study
was the small sample size. This was driven by the inten-
sive immunologic testing performed on specimens from
each participant. Statistically significant genetic associa-
tions were indeed identified, but the sample was under-
powered (with either traditional methods or MDR analy-
sis) to detect other potential associations. Additionally,
even for the positive associations detected, reliable esti-
mates of effect size cannot be determined, due to the
“winner’sc u r s e ” related to the small sample size[15].
Table 6 shows the detectable effect sizes with the cur-
rent sample size for the variants previously associated
with tuberculosis. These calculations assume 80% power
and an uncorrected alpha of 0.05%. Larger studies are
needed in which candidate gene polymorphisms and
associated cytokine pathways are fully evaluated in all
patients, so that any genetic polymorphisms identified
can be interpreted in the context of the cytokine
abnormalities noted. Given this, one should consider the
r e s u l t so ft h i ss t u d y –particularly those from the candi-
date gene approach and interaction analysis–as hypoth-
esis-generating rather than hypothesis-confirming.
While MDR has greater statistical power than traditional
methods, its power to detect gene-gene and gene-envir-
onment interactions is less than that to detect main
effects. In searching for interactive effects, the small
sample size did not allow for investigating interactions
with more than two loci.
There were other limitations of this study. First, of the
SNPs tested that had previously been associated with
tuberculosis, most pertained to pulmonary rather than
extrapulmonary disease. Due to possible differences in
the pathophysiology of these two disease manifestations,
[7] one might expect that not all of the SNPs tested
would be related to the pathogenesis of extrapulmonary
tuberculosis. Second, not all genes that are presumably
associated with tuberculosis pathogenesis had SNPs
included in the GeneChip® Human Mapping 50K Xba
Array, so not all such genes could be assessed. Third,
we were unable to directly incorporate cytokine
response data into the genetic analyses because the
methodology used to quantifyc y t o k i n er e s p o n s e sw a s
not the same in the two immunologic studies.
Additionally, concerns with multiple testing arise
when screening such a large number of genetic variants.
The results of the first approach are presented without
any corrections for multiple testing. Because these var-
iants have been associated with tuberculosis before, each
test represents an independent statistical hypothesis. By
using MDR and permutation in the second approach, P
values were empirically derived based on the total num-
ber of tests at each stage.
Conclusions
The results of this study suggest that an evaluation of
the underlying mechanism(s) of the genetic variants in
IL-1b +3953, VDR Fok1 A/G, and the TLR2 microsatel-
lite–and their role in the pathogenesis of extrapulmon-
ary tuberculosis–is warranted. Comprehensive
immunogenetic studies will contribute to our under-
standing of tuberculosis pathogenesis, and may allow us
to identify persons at highest risk of developing
tuberculosis.
Methods
Study participants
The study population was pooled from two immunolo-
gic studies that have been described previously; the
Table 6 Odds Ratios that Could Have Been Detected
Given the Sample Size and Minor Allele Frequency in the
Study Population
SNP rs number Minor Allele
Frequency
Detectable
Odds Ratio*
NRAMP1 INT4 rs3731865 0.12 4.19
NRAMP1 D543N rs17235409 0.07 5.42
NRAMP1 274 C/T rs2276631 0.19 3.56
SP 110 rs2114592 0.15 3.85
SP 110 rs3948464 0.13 4.06
IFNg +874 A/T rs2430561 0.29 3.26
IFNg -1616G rs2069705 0.49 3.41
IFNg +3234 rs2069718 0.43 3.27
IFNgR1 -56 C/T rs2234711 0.45 3.31
IL-1a -889 C/T rs1800587 0.38 3.22
IL-1B +3953 C/T rs1143634 0.12 4.19
IL-10 -1082 G/A rs1800896 0.35 3.21
IL-10 -592 A/C rs1800872 0.42 3.26
MBL codon 57 rs1800451 0.15 3.85
VDR Taq1 rs731236 0.26 3.31
VDR Fok1 A/G rs10735810 0.23 3.39
MCP-1 -2518 A/G rs1024611 0.19 3.56
TIRAP C558T rs7932766 0.17 3.69
P2X7 1513 A/C rs3751143 0.12 4.19
These calculations assume 80% power. This table includes SNPs that have
previously been reported to be associated with tuberculosis.
*Odds ratios greater than this value could have been detected in this study.
Motsinger-Reif et al. BMC Medical Genetics 2010, 11:37
http://www.biomedcentral.com/1471-2350/11/37
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described in detail elsewhere[6,7]. Briefly, patients were
identified through the Baltimore City Health Depart-
ment Eastern Chest Clinic and Nashville Metropolitan
Health Department Tuberculosis Clinic. In this case-
control study, eligibility criteria for case patients
included a history of treated culture-confirmed extrapul-
monary tuberculosis, age ≥ 18 years old, and HIV-sero-
negative status. Extrapulmonary disease was defined as
any site outside of the pulmonary parenchyma. Exclu-
sion criteria included serum creatinine >2 mg/dL, use of
corticosteroids or other immunosuppressive agents at
the time of diagnosis or time of study entry, malignancy,
or diabetes mellitus. The criteria for pulmonary tubercu-
losis control patients included HIV-seronegative adults ≥
18 years old who had completed treatment for culture-
confirmed pulmonary tuberculosis, and had no evidence
of extrapulmonary tuberculosis. Positive cultures of spu-
tum, bronchoalveolar lavage, or pulmonary parenchyma
were required. Controls with latent M. tuberculosis
infection were ≥ 18 years old, HIV-seronegative, and
had a positive tuberculin skin test (defined as ≥ 10 mm
induration after intradermal placement of 5 tuberculin
units of PPD) without evidence of active tuberculosis.
Participants in this control group were U.S.-born (and
therefore not vaccinated with BCG), and were mostly
close contacts of tuberculosis cases. Exclusion criteria
for both control groups were the same as for the case
group. Controls were drawn from the same two clinic
populations as cases, and were not related to the cases.
Extrapulmonary tuberculosis cases and pulmonary con-
trols completed treatment prior to study entry.
This study was approved by the institutional review
boards of the Johns Hopkins Hospital, the Baltimore
City Health Department, the National Institutes of
Health, Vanderbilt University Medical Center, and the
Nashville Metropolitan Health Department. All study
participants provided written informed consent.
Sample Collection
CD4+ lymphocytes were quantified by flow cytometry.
DNA was extracted from blood samples using the Pure-
gene DNA Isolation kit (Gentra Systems, Minneapolis,
MN) following the manufacturer’s protocol. Genomic
DNA was stored at -70°C until genotyping. Laboratory
personnel were blinded to the case-control status of the
specimens.
SNP Genotyping
As of November 15, 2006, 27 SNPs were identified in
the literature as being associated with tuberculosis
(Table 2). SNPs not included in the GeneChip® Human
Mapping 50K Xba Array (see below) were genotyped
using validated TaqMan SNP genotyping assays from
Applied Biosystems. For each SNP, 25 ng DNA was
used. The polymerase chain reaction (PCR) was per-
formed in an ABI 9700 thermocycler under the follow-
ing conditions: 95°C for 10 minutes followed by 50
cycles of 92°C for 15 seconds and 60°C for 1 minute.
The 384-well plates were read on an ABI 7900HT
sequence detection system according to manufacturer’s
manual. The probes were labeled with FAM or VIC dye
at the 5’ end and a minor-groove binder and non-fluor-
escent quencher at the 3’ end.
Microsatellite Genotyping
As of November 15, 2006, 3 microsatellites were identi-
fied in the literature as being associated with tuberculo-
sis (Table 2). A 5’(GT)n microsatellite associated with
NRAMP1, a VNTR associated with interleukin (IL)-
1RA, and a GT repeat polymorphism in the toll-like
receptor (TLR) 2 gene were all genotyped using fluores-
cent fragment analysis [16]. All 3 microsatellites were
amplified by PCR. The PCR primers and conditions for
the 5’(GT)n and IL-1RA microsatellites were previously
reported[17,10]. The TLR2 microsatellite was amplified
using the following conditions: 1 minute at 96°C; 30
cycles of 94°C for 1 minute, 1 minute at 53°C, and 2
minutes at 70°C; and a final elongation period of 10
minutes at 70°C. The primers used to amplify the TLR2
microsatellite were previously published [18]. The for-
ward primers for NRAMP1, IL-1RA and TLR2 microsa-
tellites (5’-ACT CGC ATT AGG CCA ACG AG-3’,5 ’-
CTC AGC AAC ACT CCT AT-3’,a n d5 ’-GCA TTG
CTG AAT GTA TCA GGG A-3’ respectively) were all
5’ labeled with FAM purchased from MWG Biotech.
Following PCR, the amplicons were electrophoresed on
a 3730s DNA analyzer (Applied Biosystems) and ana-
lyzed with GeneMapper 4.0 (Applied Biosystems).
Candidate Gene Genotyping
Twenty six candidate genes were identified based on
their potential role in tuberculosis immunopathogen-
e s i sa n dt h ei n c l u s i o no fS N P si nt h e s eg e n e si nt h e
GeneChip® Human Mapping 50K Xba Array (Affyme-
t r i x ,I n c . ,S a n t aC l a r a ,C A ) .At o t a lo f6 6 1S N P si n
these 26 candidate genes were present (Table 4). Geno-
typing was performed according to the manufacturer’s
protocol. Briefly, a complexity reduction process was
performed where genomic DNA (250 ng) was digested
with XbaI, ligated to XbaI adaptor (Affymetrix), and
amplified by polymerase chain reaction (PCR) using
primers specific to the ligated adaptor. Cycling condi-
tions were an initial denaturation of 94°C for 3 minutes
followed by 30 cycles of 94°C for 30 seconds, 60°C for
45 seconds, and 68°C for 60 seconds. A final extension
of 68°C for 7 minutes concluded the reactions. PCR
products were assayed by gel electrophoresis, purified,
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trix), biotin end-labeled with terminal deoxynucleotidyl
transferase, and hybridized to the 50K Xba Array at 48°
C for 16 hours at 60 rpm. The hybridized arrays were
washed and stained on Fluidics Station 450 and
scanned with the GeneChip Scanner according to the
manufacturer’s settings (Affymetrix). The arrays were
analyzed with software GDAS version 3.0.2 (Affyme-
trix), which provides rank scores for the probability of
particular genotypes at SNP loci. The scores were AA
or BB for homozygous alleles and AB for heterozygous
alleles, and confidence scores showed the accuracy of
the genotype call. Standard procedures and default ana-
lysis parameters for individual DNA samples were
employed. An internal control run in parallel did not
detect any DNA contamination. All procedures were
performed using the same lots of reagents.
Quality Control
Genotype calling was performed using GDAS version
3.0.2 software as noted above. This software uses the
Dynamic Models algorithm for genotype calling [19]. All
markers with significant (P < 0.05 after Bonferroni cor-
rection) departure from Hardy-Weinberg equilibrium
were excluded from final analyses. In addition, SNPs in
the GeneChip® Human Mapping 50K Xba Array with
<90% efficiency (>10% missing data) were excluded from
the analysis. Missing data patterns did not deviate from
random expectations.
Statistical Analysis
Clinical and demographic characteristics were compared
among the three patient groups (extrapulmonary tuber-
culosis, pulmonary tuberculosis, and PPD+) using the
Kruskal-Wallis test for continuous variables and the chi-
squared and Fisher exact tests for categorical variables.
Missing observations were individually excluded from all
stages of analyses (for both the univariate and MDR
analyses (no imputation was performed).
Two populations were assessed for genetic factors
associated with extrapulmonary tuberculosis: 1) all indi-
viduals regardless of race; 2) only black participants.
This stratified analysis was performed to minimize spur-
ious associations due to population stratification [20].
There were not enough individuals to perform analyses
stratified by other racial groups. The two populations
were further divided into three subgroups for associa-
tion analyses: a) any tuberculosis vs. PPD+; b) extrapul-
monary tuberculosis vs. PPD+; and c) extrapulmonary
vs. pulmonary tuberculosis.
Figure 1 Summary of the general steps to implement the MDR method, adapted from Ritchie and Motsinger 2005 [52]. In step one, the
exhaustive list of n combinations are generated from the pool of all independent variables. In step two, for k =1t oN, the combinations are
represented in k-dimensional space, and the number of responders and non-responders are counted in each multifactor cell. In step three, the
ratio of responders to non-responders is calculated within each cell. In step four, each multifactor cell in the k-dimensional space is labeled as
high-likelihood/high-risk if the ratio of responsive individuals to non-responsive individuals exceeds a threshold and low-likelihood/low-risk if the
threshold is not exceeded. In step five the training accuracy is calculated. This is then repeated for each multifactor combination. In step seven,
the model with the best training accuracy is selected and evaluated in the test set. In step eight, the testing accuracy of the model is estimated.
In step nine a permutation test is conducted to determine the statistical significance of the model(s). Steps 1 through 6 are repeated for each
possible cross-validation interval. Bars represent hypothetical distributions of responders (left) and non-responders (right) with each multifactor
combination. Dark-shaded cells represent high-likelihood genotype combinations while light-shaded cells represent low-likelihood genotype
combinations.
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below). Single locus chi-squared association tests (geno-
typic tests, with 2 degrees of freedom) (STATA version
9.0; College Station, TX) were performed on variants
previously reported to be associated with tuberculosis
susceptibility. MDR analyses were performed both on
previously reported variants and on variants in candidate
genes. MDR was performed to explore potential single-
locus associations and gene-gene interactions between
variants[21]. Details of the MDR algorithm and imple-
mentation are described in the Additional file 1 and
Figure 1.
The first stage of the genetic analysis examined variants
reported to be associated with tuberculosis susceptibility
in previous studies (Table 2). Because each variant
represented a distinct statistical hypothesis (since each
was being evaluated for replication), no correction for
multiple testing was used.
In the second stage of genetic analysis, a nested candi-
date-gene study was compiled from the Affymetrix Xba
genotyping arrays. Only SNPs in genes hypothesized to
play a role in tuberculosis pathogenesis were included
(see Table 4).
A Linux version of the MDR software was used for
data analysis (compiled and benchmarked on a PC with
a 600 MHz Pentium-III running Red Hat 2.2.5-15, writ-
ten in C and compiled with the GNU C compiler). Pre-
sently, MDR software is being distributed in a JAVA
version with a graphical user interface http://www.epis-
tasis.org/mdr.html.
For both analysis stages MDR was also performed
with genetic factors plus CD4+ lymphocytes and body
mass index (BMI). This allowed for exploration of both
gene-gene and gene-clinical factor interactions.
Additional file 1: Appendix. Description of the Multifactor
Dimensionality Reduction (MDR) Algorithm and its Implementation.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2350-11-
37-S1.DOC]
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